3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
21
Urinary Bladder Neoplasms
8
Biliary Tract Neoplasms
7
Non-Muscle Invasive Bladder Neoplasms
6
Nasopharyngeal Carcinoma
6
Nasopharyngeal Neoplasms
5
Cholangiocarcinoma
5
Ovarian Neoplasms
3
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Pancreatic Cancer Resectable
2
Neoplasm Metastasis
2
Lymphoma, Extranodal NK-T-Cell
2
Thyroid Neoplasms
1
Rhabdoid Tumor
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Rare Tumour
1
Pancreatic cancer, adult
1
Pancreatic Cancer Non-resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Mibc
1
Melanoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Locally Advanced Pancreatic Cancer
1
Liver Neoplasms
1
Klatskin Tumor
1
Interventions
pembrolizumab
1
Gemcitabine
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Klatskin Tumor
×
Gemcitabine
×
Clear all
NCT06923475
2025-04-11
NEODISCO
Amsterdam UMC, location VUmc
Phase 2/3
Not yet recruiting
150 enrolled